RXR Acquisition Corp.
RXR Acquisition Corp. Fundamental Analysis
RXR Acquisition Corp. (RXRAW) shows weak financial fundamentals with a PE ratio of 59.56, profit margin of 0.00%, and ROE of -34.88%. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of -8.9/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze RXRAW's fundamental strength across five key dimensions:
Efficiency Score
WeakRXRAW struggles to generate sufficient returns from assets.
Valuation Score
ModerateRXRAW shows balanced valuation metrics.
Growth Score
WeakRXRAW faces weak or negative growth trends.
Financial Health Score
ExcellentRXRAW maintains a strong and stable balance sheet.
Profitability Score
WeakRXRAW struggles to sustain strong margins.
Key Financial Metrics
Is RXRAW Expensive or Cheap?
P/E Ratio
RXRAW trades at 59.56 times earnings. This suggests a premium valuation.
PEG Ratio
When adjusting for growth, RXRAW's PEG of 0.60 indicates potential undervaluation.
Price to Book
The market values RXR Acquisition Corp. at -20.77 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 0.07 times EBITDA. This is generally considered low.
How Well Does RXRAW Make Money?
Net Profit Margin
For every $100 in sales, RXR Acquisition Corp. keeps $0.00 as profit after all expenses.
Operating Margin
Core operations generate 0.00 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $-34.88 in profit for every $100 of shareholder equity.
ROA
RXR Acquisition Corp. generates $2.10 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
FCF Per Share
Each share generates $-0.03 in free cash annually.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
59.56
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.60
vs 25 benchmark
P/B Ratio
Price to book value ratio
-20.77
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.00
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.00
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.56
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
-0.35
vs 25 benchmark
ROA
Return on assets percentage
0.02
vs 25 benchmark
ROCE
Return on capital employed
-0.00
vs 25 benchmark
How RXRAW Stacks Against Its Sector Peers
| Metric | RXRAW Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 59.56 | 18.83 | Worse (Expensive) |
| ROE | -34.88% | 817.00% | Weak |
| Net Margin | 0.00% | 1784.00% | Weak |
| Debt/Equity | 0.00 | 0.99 | Strong (Low Leverage) |
| Current Ratio | 1.56 | 661.85 | Neutral |
| ROA | 2.10% | -23754.00% (disorted) | Weak |
RXRAW outperforms its industry in 1 out of 6 key metrics, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews RXR Acquisition Corp.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Value, Dividend, Cyclical
EPS CAGR
N/A
Industry Style: Value, Dividend, Cyclical
FCF CAGR
N/A
Industry Style: Value, Dividend, Cyclical